Lucerastat is under investigation in clinical trial NCT03425539 (Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.